118 results on '"Winter, Peter S."'
Search Results
2. Deciphering the immunopeptidome in vivo reveals new tumour antigens
3. Mutation and cell state compatibility is required and targetable in Ph+ acute lymphoblastic leukemia minimal residual disease
4. Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer
5. A knockoff calibration method to avoid over-clustering in single-cell RNA-sequencing
6. Abstract A093: Deciphering acquired resistance to KRASG12D inhibition in a mouse model of pancreatic ductal adenocarcinoma
7. Abstract C058: Identifying cell-intrinsic drivers of transcriptional plasticity in pancreatic cancer
8. Optofluidic real-time cell sorter for longitudinal CTC studies in mouse models of cancer
9. Using antagonistic pleiotropy to design a chemotherapy-induced evolutionary trap to target drug resistance in cancer
10. Mapping Effector–Phenotype Landscapes in KRAS-Driven Cancers
11. P1207: SERIAL SINGLE-CELL PROFILING OF MANTLE CELL LYMPHOMA REVEALS FUNCTIONAL AND MOLECULAR CORRELATES OF RESISTANCE TO BTK INHIBITOR-INCLUSIVE TRIPLET THERAPY
12. A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor Evolution
13. ABL kinases regulate the stabilization of HIF-1α and MYC through CPSF1
14. Supplementary Figure Legends from CDK4/6 Therapeutic Intervention and Viable Alternative to Taxanes in CRPC
15. Supplementary Figures 1-4 from CDK4/6 Therapeutic Intervention and Viable Alternative to Taxanes in CRPC
16. Data from CDK4/6 Therapeutic Intervention and Viable Alternative to Taxanes in CRPC
17. Deciphering the immunopeptidome in vivo reveals new tumour antigens
18. Supplementary Data from Spatially Resolved Single-Cell Assessment of Pancreatic Cancer Expression Subtypes Reveals Co-expressor Phenotypes and Extensive Intratumoral Heterogeneity
19. Compressed phenotypic screens for complex multicellular models and high-content assays
20. MCB-613 exploits a collateral sensitivity in drug resistantEGFR-mutant non-small cell lung cancer through covalent inhibition of KEAP1
21. Spatially Resolved Single-Cell Assessment of Pancreatic Cancer Expression Subtypes Reveals Co-expressor Phenotypes and Extensive Intratumoral Heterogeneity
22. Systematic mapping of BCL-2 gene dependencies in cancer reveals molecular determinants of BH3 mimetic sensitivity
23. Cancer tissue of origin constrains the growth and metabolism of metastases
24. Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer
25. Metabolic programming and PDHK1 control [CD4.sup.+] T cell subsets and inflammation
26. Targeting MCL-1/BCL-XL Forestalls the Acquisition of Resistance to ABT-199 in Acute Myeloid Leukemia
27. Deciphering the tumor-specific immunopeptidome in vivo with genetically engineered mouse models
28. Optofluidic real-time cell sorter for longitudinal CTC studies in mouse models of cancer
29. Abstract PO-058: Transcriptional subtype-specific microenvironmental crosstalk and tumor cell plasticity in metastatic pancreatic cancer
30. Abstract PR-006: Spatially resolved, single cell assessment of pancreatic ductal adenocarcinoma expression subtypes reveals mixed and hybrid basal-classical marker expression with prognostic significance and discrete spatial localization
31. Abstract IA20: Aberrant leukemic developmental hierarchies and MRD-specific targeting informed by single-cell biophysical and molecular profiling
32. Abstract PR03: Subtype-specific microenvironmental crosstalk and tumor cell plasticity in metastatic pancreatic cancer
33. The tumor microenvironment drives transcriptional phenotypes and their plasticity in metastatic pancreatic cancer
34. Abstract PR02: Matched metastatic pancreatic ductal adenocarcinoma biopsies and organoid models reveal tumor cell transcriptional plasticity and subtype-specific microenvironmental crosstalk
35. Abstract PR15: Assessment of tumor heterogeneity, clonal evolution, and the stromal microenvironment in metastatic pancreatic ductal adenocarcinoma and matched patient-derived organoids
36. Abstract 2450: Single-cell profiling reveals programs mediating oncogenic kinase-independence and minimal residual disease in BCR-ABL-rearranged acute lymphoblastic leukemia
37. CDK4/6 Therapeutic Intervention and Viable Alternative to Taxanes in CRPC
38. Epstein-Barr virus ensures B cell survival by uniquely modulating apoptosis at early and late times after infection
39. Author response: Epstein-Barr virus ensures B cell survival by uniquely modulating apoptosis at early and late times after infection
40. PIK3CA mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translation
41. Mapping nucleosome positions using DNase-seq
42. Functional Analysis of the CML Blast Crisis Transcriptome and Epigenome Using Crispr-CAS9 and Pharmacologic Approaches
43. Systematic identification of signaling pathways with potential to confer anticancer drug resistance
44. RAS signaling promotes resistance to JAK inhibitors by suppressing BAD-mediated apoptosis
45. Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation
46. Systemic Acquired Resistance in Moss: Further Evidence for Conserved Defense Mechanisms in Plants
47. A Landscape of Therapeutic Cooperativity in KRASMutant Cancers Reveals Principles for Controlling Tumor Evolution
48. Epstein-Barr virus ensures B cell survival by uniquely modulating apoptosis at early and late times after infection
49. Targeting MCL-1/BCL-XL Forestalls the Acquisition of Resistance to ABT-199 in Acute Myeloid Leukemia.
50. PIK3CAmutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.